Walgreens Boots Alliance (NASDAQ:WBA) Issues FY25 Earnings Guidance

Walgreens Boots Alliance (NASDAQ:WBA) issued an update on its FY25 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of $1.40-$1.80 for the period, compared to the consensus estimate of $1.52. Walgreens Boots Alliance also updated its FY 2025 guidance to 1.400-1.800 EPS.

Walgreens Boots Alliance Trading Down 4.7 %

NASDAQ WBA opened at $9.22 on Friday. Walgreens Boots Alliance has a one year low of $8.08 and a one year high of $25.63. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.37 and a current ratio of 0.68. The company has a market capitalization of $7.96 billion, a price-to-earnings ratio of -0.92, a price-to-earnings-growth ratio of 1.36 and a beta of 0.64. The company’s 50-day simple moving average is $9.21 and its two-hundred day simple moving average is $9.92.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.13. The company had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. Walgreens Boots Alliance’s revenue was up 7.6% compared to the same quarter last year. During the same period last year, the company posted $0.66 earnings per share. Equities analysts forecast that Walgreens Boots Alliance will post 1.53 EPS for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, December 12th. Investors of record on Monday, November 18th were given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 10.85%. The ex-dividend date of this dividend was Monday, November 18th. Walgreens Boots Alliance’s payout ratio is currently -9.99%.

Wall Street Analyst Weigh In

WBA has been the subject of several recent analyst reports. Evercore ISI boosted their price objective on shares of Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an “in-line” rating in a research note on Wednesday, October 16th. UBS Group increased their price objective on Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a report on Thursday, October 17th. Royal Bank of Canada lowered their price objective on Walgreens Boots Alliance from $13.00 to $9.00 and set a “sector perform” rating for the company in a research report on Wednesday, December 4th. Truist Financial reduced their target price on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating on the stock in a research report on Monday, October 7th. Finally, Jefferies Financial Group lowered their target price on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a research note on Wednesday, October 23rd. Four investment analysts have rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $12.58.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.